تداخل‌های دارویی
Brexucabtagene autoleucel + Natalizumab
شدت: شدید
Brexucabtagene autoleucel and Natalizumab: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
معنای این تداخل به زبان ساده
Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Natalizumab belongs to Gastrointestinal Tract.
چرا رخ می‌دهد
Additive immunosuppression from impaired lymphocyte trafficking and CAR T-related immune depletion.
اقدام لازم
Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Brexucabtagene autoleucel و Natalizumab، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Natalizumab
تداخلات دیگر Brexucabtagene autoleucel
پرسش‌های متداول
Can I take Brexucabtagene autoleucel with Natalizumab?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
How serious is the interaction between Brexucabtagene autoleucel and Natalizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
